Zimmer Biomet Holdings ROCE 2024

Zimmer Biomet Holdings ROCE

0.12

Zimmer Biomet Holdings Dividend yield

0.82 %

Ticker

ZBH

ISIN

US98956P1021

WKN

753718

In 2024, Zimmer Biomet Holdings's return on capital employed (ROCE) was 0.12, a 15.72% increase from the 0.1 ROCE in the previous year.

Zimmer Biomet Holdings Aktienanalyse

What does Zimmer Biomet Holdings do?

Zimmer Biomet Holdings Inc is a global company in the medical technology industry that provides innovative products and solutions for orthopedic, dental, and surgical applications. The company was formed through the merger of Zimmer Holdings Inc and Biomet Inc in 2015 and is headquartered in Indiana, USA. The history of Zimmer Biomet Holdings dates back to 1927 when Justin Zimmer founded Zimmer Manufacturing Company, which specialized in the production of orthopedic instruments and prostheses. In 1939, the company introduced the first modular hip endoprosthesis and over the years established itself as a leading provider of orthopedic implants and instruments. Biomet Inc was founded in 1977 with the goal of developing groundbreaking solutions for orthopedic implants. Both companies grew rapidly through acquisitions, strategic partnerships, and innovations before eventually merging. The business model of Zimmer Biomet Holdings focuses on supporting patients and medical professionals in improving quality of life and health. The company offers a wide range of products and services tailored to the needs of patients and medical professionals. These range from joint implants, spine, and knee instruments to digital solutions and patient care services. The company operates in various divisions specializing in different areas of medical technology. The Joint Reconstruction division offers a comprehensive range of implants for hips, knees, shoulders, and elbows, as well as instruments required for orthopedic and surgical procedures. The Surgical division provides products and solutions for surgical procedures, including spine, sports, and trauma surgery. Dental supplies products for dentistry, including implants, instruments, and digital solutions. Additionally, there is the Craniomaxillofacial and Thoracic Surgery division, which focuses on providing care for patients with bone and soft tissue tumors, as well as facial trauma reconstruction. Zimmer Biomet Holdings products are distributed in over 100 countries worldwide and are recognized by medical professionals and patients alike. Some of the most well-known products include the NexGen hip and knee prostheses, Trabecular Metal implants, and digital solutions for patient care such as the Zimmer Biomet mymobility service. In addition to its products and services, Zimmer Biomet Holdings pursues a variety of initiatives and partnerships to improve healthcare and patient outcomes. This includes research projects in collaboration with universities, research institutions, and medical societies, as well as the exchange of best practices among medical professionals. Overall, Zimmer Biomet Holdings has established itself as a leading provider of innovative products and solutions for orthopedic, dental, and surgical applications. With its comprehensive range of products and services and global presence, the company sets standards for healthcare and patient care. Zimmer Biomet Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Zimmer Biomet Holdings's Return on Capital Employed (ROCE)

Zimmer Biomet Holdings's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Zimmer Biomet Holdings's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Zimmer Biomet Holdings's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Zimmer Biomet Holdings’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Zimmer Biomet Holdings Stock

What is the ROCE (Return on Capital Employed) of Zimmer Biomet Holdings this year?

The ROCE of Zimmer Biomet Holdings is 0.12 undefined this year.

How has the ROCE (Return on Capital Employed) of Zimmer Biomet Holdings developed compared to the previous year?

The ROCE of Zimmer Biomet Holdings has increased by 15.72% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Zimmer Biomet Holdings?

A high Return on Capital Employed (ROCE) indicates that Zimmer Biomet Holdings has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Zimmer Biomet Holdings?

A low ROCE (Return on Capital Employed) can indicate that Zimmer Biomet Holdings has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Zimmer Biomet Holdings impact the company?

An increase in the ROCE of Zimmer Biomet Holdings can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Zimmer Biomet Holdings affect the company?

A decrease in ROCE of Zimmer Biomet Holdings can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Zimmer Biomet Holdings?

Some factors that can affect Zimmer Biomet Holdings's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Zimmer Biomet Holdings so important for investors?

The ROCE of Zimmer Biomet Holdings is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Zimmer Biomet Holdings take to improve the ROCE?

To improve the ROCE, Zimmer Biomet Holdings can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Zimmer Biomet Holdings pay?

Over the past 12 months, Zimmer Biomet Holdings paid a dividend of 0.96 USD . This corresponds to a dividend yield of about 0.82 %. For the coming 12 months, Zimmer Biomet Holdings is expected to pay a dividend of 0.97 USD.

What is the dividend yield of Zimmer Biomet Holdings?

The current dividend yield of Zimmer Biomet Holdings is 0.82 %.

When does Zimmer Biomet Holdings pay dividends?

Zimmer Biomet Holdings pays a quarterly dividend. This is distributed in the months of October, January, April, July.

How secure is the dividend of Zimmer Biomet Holdings?

Zimmer Biomet Holdings paid dividends every year for the past 17 years.

What is the dividend of Zimmer Biomet Holdings?

For the upcoming 12 months, dividends amounting to 0.97 USD are expected. This corresponds to a dividend yield of 0.83 %.

In which sector is Zimmer Biomet Holdings located?

Zimmer Biomet Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Zimmer Biomet Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zimmer Biomet Holdings from 7/31/2024 amounting to 0.24 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Zimmer Biomet Holdings pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Zimmer Biomet Holdings in the year 2023?

In the year 2023, Zimmer Biomet Holdings distributed 0.96 USD as dividends.

In which currency does Zimmer Biomet Holdings pay out the dividend?

The dividends of Zimmer Biomet Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Zimmer Biomet Holdings stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Zimmer Biomet Holdings

Our stock analysis for Zimmer Biomet Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zimmer Biomet Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.